ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ADZENYS ER
ADHD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ADZENYS ER CII

Generic Name and Formulations:
Amphetamine ext-rel 1.25mg/mL; oral susp; orange-flavored.

Company:
Neos Therapeutics

Therapeutic Use:

Indications for ADZENYS ER:

Attention deficit hyperactivity disorder.

Adults and Children:

Do not substitute for other amphetamine products on a mg-per-mg basis. <6yrs: not established. Individualize. Take in the AM. 6–17yrs: initially 6.3mg (5mL) once daily; increase in increments of 3.1mg (2.5mL) or 6.3mg (5mL) at weekly intervals; max 18.8mg (15mL) daily (if 6–12yrs) or 12.5mg (10mL) daily (if 13–17yrs). >17yrs: 12.5mg (10mL) once daily. Switching from other amphetamine products: see full labeling.

Contraindications:

During or within 14 days of MAOIs.

Boxed Warning:

Abuse and dependence.

Warnings/Precautions:

Abuse potential (monitor). Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating. Avoid in known structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder. Screen for risk factors in developing manic episode prior to initiating. Consider discontinuing if new psychotic/manic symptoms occur. Monitor for serotonin syndrome; discontinue if occurs. Peripheral vasculopathy, including Raynaud's phenomenon; monitor for digital changes. Monitor BP, HR, growth in children. Reevaluate periodically. Labor & delivery. Pregnancy; monitor for neonatal withdrawal symptoms. Nursing mothers: not recommended.

Pharmacological Class:

CNS stimulant.

Interactions:

See Contraindications. Hypertensive crisis with MAOIs (including linezolid, IV methylene blue). Increased risk of serotonin syndrome with serotonergic drugs (eg, SSRIs, SNRIs, TCAs, triptans, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's wort), CYP2D6 inhibitors (eg, paroxetine, fluoxetine, quinidine, ritonavir); consider alternatives; if needed, initiate with lower doses and monitor. Potentiated by urinary alkalinizers (eg, sodium bicarbonate, acetazolamide, some thiazides); avoid. Antagonized by acidifiers (eg, ascorbic acid, guanethidine, reserpine, glutamic acid HCl): increase dose as needed. Concomitant gastric pH modulators (eg, omeprazole, esomeprazole, pantoprazole, cimetidine): not recommended. May potentiate TCAs or sympathomimetics; adjust dose or use alternatives. May interfere with urinary steroid tests.

Adverse Reactions:

Loss of appetite, insomnia, abdominal pain, emotional lability, vomiting, nervousness, nausea, fever; hypertension. Also adults: dry mouth, headache, weight loss, anxiety, agitation, dizziness, tachycardia, diarrhea, asthenia, urinary tract infections.

Note:

To register pregnant patients in the National Pregnancy Registry for Psychostimulants, call (866) 961-2388.

Generic Availability:

NO

How Supplied:

Susp—450mL

Sign Up for Free e-newsletters



CME Focus